
Diadia Health is an AI-driven medical reasoning platform that provides personalized health insights and protocols based on comprehensive lab analyses. The company focuses on uncovering root causes of health issues, particularly for women experiencing hormonal imbalances and metabolic dysfunctions. By analyzing over 200 biomarkers, Diadia offers tailored recommendations that empower users to take control of their health. With a mission to extend health spans, Diadia aims to transform preventative care through advanced AI technology, making it accessible and effective for individuals seeking to improve their well-being.

Diadia Health is an AI-driven medical reasoning platform that provides personalized health insights and protocols based on comprehensive lab analyses. The company focuses on uncovering root causes of health issues, particularly for women experiencing hormonal imbalances and metabolic dysfunctions. By analyzing over 200 biomarkers, Diadia offers tailored recommendations that empower users to take control of their health. With a mission to extend health spans, Diadia aims to transform preventative care through advanced AI technology, making it accessible and effective for individuals seeking to improve their well-being.
What they do: AI-driven clinical decision-support platform that analyzes genetic and biomarker data to identify root causes and generate personalized protocols
Focus: Emphasis on women's health, hormonal imbalances, and metabolic dysfunction
Scale claims: States coverage of 700K+ genetic variants, 100+ metabolic pathways, and 310K+ research papers
Team size: 7 employees (reported)
Funding: $10M total; Seed round activity reported
Women’s health, hormonal imbalances, metabolic dysfunction; root-cause analysis from biomarkers and genetics.
Health technology / Clinical decision support
Crunchbase lists Salesforce Ventures as lead investor; company reports ~$10M total funding across rounds
“Salesforce Ventures; Sound Ventures; Tribe Capital; Polygon Ventures; Orange DAO; Monochrome Capital”